Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R8JK
|
||||
| Former ID |
DNC009660
|
||||
| Drug Name |
N-phenyl-6-(sulfamoylamino)hexanamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529866] | ||
| Formula |
C12H19N3O3S
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)NC(=O)CCCCCNS(=O)(=O)N
|
||||
| InChI |
1S/C12H19N3O3S/c13-19(17,18)14-10-6-2-5-9-12(16)15-11-7-3-1-4-8-11/h1,3-4,7-8,14H,2,5-6,9-10H2,(H,15,16)(H2,13,17,18)
|
||||
| InChIKey |
GJBBLVDVDAQQMI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Histone deacetylase 6 | Target Info | Inhibitor | [529866] | |
| KEGG Pathway | Alcoholism | ||||
| Viral carcinogenesis | |||||
| Pathway Interaction Database | Signaling events mediated by HDAC Class II | ||||
| Signaling events mediated by HDAC Class I | |||||
| References | |||||